Kenneth F. Bradstock

Kenneth F. Bradstock

Camperdown, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol.

Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol.

Journal: Blood neoplasia

Published: March 06, 2024

Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase.

Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase.

Journal: Leukemia & lymphoma

Published: July 30, 2023

Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR.

Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR.

Journal: The Journal of molecular diagnostics : JMD

Published: August 04, 2021

An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL.

An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL.

Journal: Blood advances

Published: June 21, 2021

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

Journal: Blood advances

Published: August 27, 2019

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

Journal: Molecular oncology

Published: June 05, 2019

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma.

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma.

Journal: Leukemia & lymphoma

Published: December 15, 2018

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies.

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies.

Journal: Blood cancer journal

Published: June 07, 2018

Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell Transplantation.

Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell Transplantation.

Journal: HLA

Published: January 29, 2018

Identification of sphingosine kinase 1 as a therapeutic target in B-lineage acute lymphoblastic leukaemia.

Identification of sphingosine kinase 1 as a therapeutic target in B-lineage acute lymphoblastic leukaemia.

Journal: British journal of haematology

Published: January 24, 2018

Unmet supportive care needs of haematological cancer survivors: rural versus urban residents.

Unmet supportive care needs of haematological cancer survivors: rural versus urban residents.

Journal: Annals of hematology

Published: December 28, 2017

A national study of the unmet needs of support persons of haematological cancer survivors in rural and urban areas of Australia.

A national study of the unmet needs of support persons of haematological cancer survivors in rural and urban areas of Australia.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 23, 2017

Showing 1-12 of 44

Last Updated: 09/26/2026